Glioblastoma    AO1_L_S_OW0 N_OW1_N AE1_Z glioblastoma multiforme    GBM     IH1_Z DH_AH0 M_OW1_S_T AH0_G_R_EH1_S_IH0_V K_AE1_N_S_ER0 DH_AE1_T B_IH0_G_IH1_N_Z W_IH0_DH_IH1_N DH_AH0 B_R_EY1_N    Initially    S_AY1_N_Z AH0_N_D S_IH1_M_P_T_AH0_M_Z AH1_V glioblastoma AA1_R N_AA1_N S_P_AH0_S_IH1_F_IH0_K    They M_EY1 IH2_N_K_L_UW1_D HH_EH1_D_EY2_K_S    P_ER2_S_AH0_N_AE1_L_IH0_T_IY0 CH_EY1_N_JH_AH0_Z    N_AO1_Z_IY0_AH0    AH0_N_D S_IH1_M_P_T_AH0_M_Z S_IH1_M_AH0_L_ER0 T_UW1 DH_OW1_Z AH1_V AH0 S_T_R_OW1_K    Worsening AH1_V S_IH1_M_P_T_AH0_M_Z AO1_F_T_AH0_N IH1_Z R_AE1_P_AH0_D    This M_EY1 P_R_AA1_G_R_EH2_S T_UW1 AH2_N_K_AA1_N_SH_AH0_S_N_IH0_S    The K_AA1_Z AH1_V M_OW1_S_T K_EY1_S_AH0_Z IH1_Z AH0_N_K_L_IH1_R    Uncommon R_IH1_S_K F_AE1_K_T_ER0_Z IH2_N_K_L_UW1_D JH_AH0_N_EH1_T_IH0_K D_IH0_S_AO1_R_D_ER0_Z S_AH1_CH AE1_Z N_UH2_R_OW0_F_AY0_B_R_OW2_M_AH0_T_OW1_S_IH0_S AH0_N_D Li Fraumeni S_IH1_N_D_R_OW2_M    AH0_N_D P_R_IY1_V_IY0_AH0_S R_EY2_D_IY0_EY1_SH_AH0_N TH_EH1_R_AH0_P_IY0     Glioblastomas R_EH2_P_R_AH0_Z_EH1_N_T 15 %  AH1_V B_R_EY1_N T_UW1_M_ER0_Z    They K_AE1_N IY1_DH_ER0 S_T_AA1_R_T F_R_AH1_M N_AO1_R_M_AH0_L B_R_EY1_N S_EH1_L_Z AO1_R D_IH0_V_EH1_L_AH0_P F_R_AH1_M AE1_N IH0_G_Z_IH1_S_T_IH0_NG L_OW1 G_R_EY1_D astrocytoma    The D_AY2_AH0_G_N_OW1_S_AH0_S T_IH1_P_IH0_K_L_IY0 IH1_Z M_EY1_D B_AY1 AH0 K_AA2_M_B_AH0_N_EY1_SH_AH0_N AH1_V CT S_K_AE1_N    MRI S_K_AE1_N    AH0_N_D T_IH1_S_Y_UW2 B_AY1_AA0_P_S_IY0    There IH1_Z N_OW1 K_L_IH1_R W_EY1 T_UW1 P_R_IH0_V_EH1_N_T DH_AH0 D_IH0_Z_IY1_Z    Typically    T_R_IY1_T_M_AH0_N_T IH2_N_V_AA1_L_V_Z S_ER1_JH_ER0_IY0    AE1_F_T_ER0 W_IH1_CH K_IY2_M_OW0_TH_EH1_R_AH0_P_IY0 AH0_N_D R_EY2_D_IY0_EY1_SH_AH0_N TH_EH1_R_AH0_P_IY0 AA1_R Y_UW1_Z_D    The M_EH2_D_AH0_K_EY1_SH_AH0_N temozolomide IH1_Z Y_UW1_Z_D F_R_IY1_K_W_AH0_N_T_L_IY0 AE1_Z P_AA1_R_T AH1_V K_IY2_M_OW0_TH_EH1_R_AH0_P_IY0      High D_OW1_S S_T_EH1_R_OY0_D_Z M_EY1 B_IY1 Y_UW1_Z_D T_UW1 HH_EH1_L_P R_IH0_D_UW1_S S_W_EH1_L_IH0_NG AH0_N_D D_IH0_K_R_IY1_S S_IH1_M_P_T_AH0_M_Z    It IH1_Z AH0_N_K_L_IH1_R W_EH1_DH_ER0 T_R_AY1_IH0_NG T_UW1 R_IY0_M_UW1_V AO1_L AO1_R S_IH1_M_P_L_IY0 M_OW1_S_T AH1_V DH_AH0 K_AE1_N_S_ER0 IH1_Z B_EH1_T_ER0    Despite M_AE1_K_S_AH0_M_AH0_M T_R_IY1_T_M_AH0_N_T    DH_AH0 K_AE1_N_S_ER0 Y_UW1_ZH_AH0_W_AH0_L_IY0 recurs    The M_OW1_S_T K_AA1_M_AH0_N L_EH1_NG_K_TH AH1_V S_ER0_V_AY1_V_AH0_L F_AA1_L_OW0_IH0_NG D_AY2_AH0_G_N_OW1_S_AH0_S IH1_Z 12 T_UW1 15 M_AH1_N_TH_S    W_IH1_DH F_Y_UW1_ER0 DH_AE1_N %  T_UW1 %  AH1_V P_IY1_P_AH0_L S_ER0_V_AY1_V_IH0_NG L_AO1_NG_G_ER0 DH_AE1_N F_AY1_V Y_IH1_R_Z     Without T_R_IY1_T_M_AH0_N_T    S_ER0_V_AY1_V_AH0_L IH1_Z T_IH1_P_IH0_K_L_IY0 TH_R_IY1 M_AH1_N_TH_S    It IH1_Z DH_AH0 M_OW1_S_T K_AA1_M_AH0_N K_AE1_N_S_ER0 DH_AE1_T B_IH0_G_IH1_N_Z W_IH0_DH_IH1_N DH_AH0 B_R_EY1_N AH0_N_D DH_AH0 S_EH1_K_AH0_N_D M_OW1_S_T K_AA1_M_AH0_N B_R_EY1_N T_UW1_M_ER0    AE1_F_T_ER0 meningioma     About P_ER1 100 000 P_IY1_P_AH0_L D_IH0_V_EH1_L_AH0_P DH_AH0 D_IH0_Z_IY1_Z AH0 Y_IH1_R    It M_OW1_S_T AO1_F_T_AH0_N B_IH0_G_IH1_N_Z ER0_AW1_N_D 64 Y_IH1_R_Z AH1_V EY1_JH AH0_N_D AH0_K_ER1_Z M_AO1_R K_AA1_M_AH0_N_L_IY0 IH0_N M_EY1_L_Z DH_AE1_N F_IY1_M_EY2_L_Z     Immunotherapy IH1_Z B_IY1_IH0_NG S_T_AH1_D_IY0_D IH0_N glioblastoma W_IH1_DH P_R_AA1_M_AH0_S_IH0_NG R_IH0_Z_AH1_L_T_S    Common S_IH1_M_P_T_AH0_M_Z IH2_N_K_L_UW1_D S_IY1_ZH_ER0    HH_EH1_D_EY2_K_S    N_AO1_Z_IY0_AH0 AH0_N_D V_AA1_M_AH0_T_IH0_NG    M_EH1_M_ER0_IY0 L_AO1_S    CH_EY1_N_JH_AH0_Z T_UW1 P_ER2_S_AH0_N_AE1_L_IH0_T_IY0    M_UW1_D AO1_R K_AA2_N_S_AH0_N_T_R_EY1_SH_AH0_N ;  AH0_N_D L_OW1_K_AH0_L_AY2_Z_D N_UH2_R_AH0_L_AA1_JH_IH0_K_AH0_L P_R_AA1_B_L_AH0_M_Z    The K_AY1_N_D AH1_V S_IH1_M_P_T_AH0_M_Z P_R_AH0_D_UW1_S_T D_IH0_P_EH1_N_D_Z M_AO1_R AA1_N DH_AH0 L_OW0_K_EY1_SH_AH0_N AH1_V DH_AH0 T_UW1_M_ER0 DH_AE1_N AA1_N IH1_T_S P_AE2_TH_AH0_L_AA1_JH_IH0_K_AH0_L P_R_AA1_P_ER0_T_IY0_Z The T_UW1_M_ER0 K_AE1_N S_T_AA1_R_T P_R_AH0_D_UW1_S_IH0_NG S_IH1_M_P_T_AH0_M_Z K_W_IH1_K_L_IY0    B_AH1_T AO0_K_EY1_ZH_AH0_N_AH0_L_IY2 IH1_Z AE1_N EY2_S_IH2_M_P_T_AH0_M_AE1_T_IH0_K K_AH0_N_D_IH1_SH_AH0_N AH0_N_T_IH1_L IH1_T R_IY1_CH_AH0_Z AE1_N IH0_N_AO1_R_M_AH0_S S_AY1_Z The K_AA1_Z AH1_V M_OW1_S_T K_EY1_S_AH0_Z IH1_Z AH0_N_K_L_IH1_R    About %  D_IH0_V_EH1_L_AH0_P F_R_AH1_M AH0_N_AH1_DH_ER0 T_AY1_P B_R_EY1_N T_UW1_M_ER0 N_OW1_N AE1_Z AH0 L_OW1 G_R_EY1_D astrocytoma    Uncommon R_IH1_S_K F_AE1_K_T_ER0_Z IH2_N_K_L_UW1_D JH_AH0_N_EH1_T_IH0_K D_IH0_S_AO1_R_D_ER0_Z S_AH1_CH AE1_Z N_UH2_R_OW0_F_AY0_B_R_OW2_M_AH0_T_OW1_S_IH0_S    Li Fraumeni S_IH1_N_D_R_OW2_M    tuberous S_K_L_ER0_OW1_S_AH0_S    AO1_R Turcot S_IH1_N_D_R_OW2_M    Previous R_EY2_D_IY0_EY1_SH_AH0_N TH_EH1_R_AH0_P_IY0 IH1_Z AO1_L_S_OW0 AH0 R_IH1_S_K     For AH0_N_N_OW1_N R_IY1_Z_AH0_N_Z    GBM AH0_K_ER1_Z M_AO1_R K_AA1_M_AH0_N_L_IY0 IH0_N M_EY1_L_Z    Other AH0_S_OW2_S_IY0_EY1_SH_AH0_N_Z IH2_N_K_L_UW1_D IH0_K_S_P_OW1_ZH_ER0 T_UW1 S_M_OW1_K_IH0_NG    P_EH1_S_T_AH0_S_AY2_D_Z    AH0_N_D W_ER1_K_IH0_NG IH0_N P_AH0_T_R_OW1_L_IY0_AH0_M R_AH0_F_AY1_N_IH0_NG AO1_R R_AH1_B_ER0 M_AE2_N_Y_AH0_F_AE1_K_CH_ER0_IH0_NG    Glioblastoma HH_AE1_Z B_IH1_N AH0_S_OW1_S_IY0_EY2_T_AH0_D W_IH1_DH DH_AH0 V_AY1_R_AH0_S_AH0_Z SV40     HHV      AH0_N_D S_AY2_T_AH0_M_EH2_G_AH0_L_OW0_V_AY1_R_AH0_S    The S_EH1_L_Y_AH0_L_ER0 AO1_R_AH0_JH_AH0_N AH1_V glioblastoma IH1_Z AH0_N_N_OW1_N    Because AH1_V DH_AH0 S_IH2_M_AH0_L_EH1_R_AH0_T_IY0_Z IH0_N immunostaining AH1_V glial S_EH1_L_Z AH0_N_D glioblastoma    IH1_T HH_AE1_Z L_AO1_NG B_IH1_N AH0_S_UW1_M_D DH_AE1_T gliomas S_AH1_CH AE1_Z glioblastoma ER0_IH1_JH_AH0_N_EY2_T F_R_AH1_M glial T_AY1_P S_EH1_L_Z    However M_AO1_R R_IY1_S_AH0_N_T S_T_AH1_D_IY0_Z S_AH0_JH_EH1_S_T DH_AE1_T astrocytes    oligodendrocyte P_R_OW0_JH_EH1_N_IH0_T_ER0 S_EH1_L_Z AH0_N_D N_UH1_R_AH0_L S_T_EH1_M S_EH1_L_Z K_UH1_D AO1_L_S_OW0 S_ER1_V AE1_Z DH_AH0 S_EH1_L AH1_V AO1_R_AH0_JH_AH0_N     Glioblastoma multiforme T_UW1_M_ER0_Z AA1_R K_EH1_R_IH0_K_T_ER0_AY2_Z_D B_AY1 DH_AH0 P_R_EH1_Z_AH0_N_S AH1_V S_M_AO1_L EH1_R_IY0_AH0_Z AH1_V necrotizing T_IH1_S_Y_UW2 DH_AE1_T AA1_R S_ER0_AW1_N_D_AH0_D B_AY1 AE2_N_AH0_P_L_AE1_S_T_IH0_K S_EH1_L_Z This K_EH2_R_IH0_K_T_ER0_IH1_S_T_IH0_K    AE1_Z W_EH1_L AE1_Z DH_AH0 P_R_EH1_Z_AH0_N_S AH1_V hyperplastic B_L_AH1_D V_EH1_S_AH0_L_Z    D_IH0_F_ER0_EH1_N_SH_IY0_EY2_T_S DH_AH0 T_UW1_M_ER0 F_R_AH1_M Grade astrocytomas    W_IH1_CH D_UW1 N_AA1_T HH_AE1_V DH_IY1_Z F_IY1_CH_ER0_Z GBMs Y_UW1_ZH_AH0_W_AH0_L_IY0 F_AO1_R_M IH0_N DH_AH0 S_EH1_R_AH0_B_R_AH0_L W_AY1_T M_AE1_T_ER0    G_R_OW1 K_W_IH1_K_L_IY0    AH0_N_D K_AE1_N B_IH0_K_AH1_M V_EH1_R_IY0 L_AA1_R_JH B_IH0_F_AO1_R P_R_AH0_D_UW1_S_IH0_NG S_IH1_M_P_T_AH0_M_Z Fewer DH_AE1_N 10 %  F_AO1_R_M M_AO1_R S_L_OW1_L_IY0 F_AA1_L_OW0_IH0_NG D_IH0_JH_EH2_N_ER0_EY1_SH_AH0_N AH1_V L_OW1 G_R_EY1_D astrocytoma AO1_R AE2_N_AH0_P_L_AE1_S_T_IH0_K astrocytoma These AA1_R K_AO1_L_D S_EH1_K_AH0_N_D_EH2_R_IY0 GBMs AH0_N_D AA1_R M_AO1_R K_AA1_M_AH0_N IH0_N Y_AH1_NG_G_ER0 P_EY1_SH_AH0_N_T_S    M_IY1_N EY1_JH 45 V_ER1_S_AH0_S 62 Y_IH1_R_Z    The T_UW1_M_ER0 M_EY1 IH0_K_S_T_EH1_N_D IH1_N_T_UW0 DH_AH0 meninges AO1_R V_EH0_N_T_R_IH1_K_Y_UW0_L_ER0 W_AO1_L    L_IY1_D_IH0_NG T_UW1 HH_AY1 P_R_OW1_T_IY2_N K_AA1_N_T_EH0_N_T IH0_N DH_AH0 cerebrospinal F_L_UW1_AH0_D    CSF    >  100 mg dL     AE1_Z W_EH1_L AE1_Z AE1_N AO0_K_EY1_ZH_AH0_N_AH0_L pleocytosis AH1_V 10 T_UW1 100 S_EH1_L_Z    M_OW1_S_T_L_IY0 L_IH1_M_F_AH0_S_AY2_T_S Malignant S_EH1_L_Z K_AE1_R_IY0_D IH0_N DH_AH0 CSF M_EY1 S_P_R_EH1_D    R_EH1_R_L_IY0    T_UW1 DH_AH0 S_P_AY1_N_AH0_L K_AO1_R_D AO1_R K_AA1_Z meningeal gliomatosis However    M_AH0_T_AE1_S_T_AH0_S_IH0_S AH1_V GBM B_IH0_AA1_N_D DH_AH0 S_EH1_N_T_R_AH0_L N_ER1_V_AH0_S S_IH1_S_T_AH0_M IH1_Z IH0_K_S_T_R_IY1_M_L_IY0 AH0_N_Y_UW1_ZH_UW2_AH0_L About 50 %  AH1_V GBMs AA1_K_Y_AH0_P_AY2 M_AO1_R DH_AE1_N W_AH1_N L_OW1_B AH1_V AH0 HH_EH1_M_IH0_S_F_IH2_R AO1_R AA1_R B_AY0_L_AE1_T_ER0_AH0_L Tumors AH1_V DH_IH1_S T_AY1_P Y_UW1_ZH_AH0_W_AH0_L_IY0 ER0_AY1_Z F_R_AH1_M DH_AH0 cerebrum AH0_N_D M_EY1    IH0_G_Z_IH1_B_IH0_T DH_AH0 K_L_AE1_S_IH0_K IH2_N_F_IH0_L_T_R_EY1_SH_AH0_N AH0_K_R_AO1_S DH_AH0 K_AO1_R_P_AH0_S callosum    P_R_AH0_D_UW1_S_IH0_NG AH0 B_AH1_T_ER0_F_L_AY2    B_AY0_L_AE1_T_ER0_AH0_L    glioma The T_UW1_M_ER0 M_EY1 T_EY1_K AA1_N AH0 V_ER0_AY1_AH0_T_IY0 AH1_V AH0_P_IH1_R_AH0_N_S_AH0_Z    D_IH0_P_EH1_N_D_IH0_NG AA1_N DH_AH0 AH0_M_AW1_N_T AH1_V HH_EH1_M_ER0_IH0_JH    N_AH0_K_R_OW1_S_AH0_S    AO1_R IH1_T_S EY1_JH CT S_K_AE1_N W_IH1_L Y_UW1_ZH_AH0_W_AH0_L_IY0 SH_OW1 AE1_N inhomogeneous M_AE1_S W_IH1_DH AH0 hypodense S_EH1_N_T_ER0 AH0_N_D AH0 V_EH1_R_IY0_AH0_B_AH0_L R_IH1_NG AH1_V EH0_N_HH_AE1_N_S_M_AH0_N_T S_ER0_AW1_N_D_AH0_D B_AY1 IH0_D_IY1_M_AH0 Mass IH0_F_EH1_K_T F_R_AH1_M DH_AH0 T_UW1_M_ER0 AH0_N_D IH0_D_IY1_M_AH0 M_EY1 K_AA1_M_P_R_EH0_S DH_AH0 ventricles AH0_N_D K_AA1_Z hydrocephalus Four subtypes AH1_V glioblastoma HH_AE1_V B_IH1_N AY0_D_EH1_N_T_AH0_F_AY2_D     Many AH1_DH_ER0 JH_AH0_N_EH1_T_IH0_K AO2_L_T_ER0_EY1_SH_AH0_N_Z HH_AE1_V B_IH1_N D_IH0_S_K_R_AY1_B_D IH0_N glioblastoma    AH0_N_D DH_AH0 M_AH0_JH_AO1_R_AH0_T_IY0 AH1_V DH_EH1_M AA1_R K_L_AH1_S_T_ER0_D IH0_N T_UW1 P_AE1_TH_W_EY2_Z    DH_AH0 RB AH0_N_D DH_AH0 PI3K AKT    Glioblastomas HH_AE1_V AO2_L_T_ER0_EY1_SH_AH0_N_Z IH0_N 68 78 %  AH0_N_D 88 %  AH1_V DH_IY1_Z P_AE1_TH_W_EY2_Z    R_IH0_S_P_EH1_K_T_IH0_V_L_IY0    Another IH2_M_P_AO1_R_T_AH0_N_T AO2_L_T_ER0_EY1_SH_AH0_N IH1_Z methylation AH1_V MGMT    AH0    S_UW1_AH0_S_AY2_D    DNA R_IH0_P_EH1_R EH1_N_Z_AY2_M Methylation IH1_Z D_IH0_S_K_R_AY1_B_D T_UW1 IH2_M_P_EH1_R DNA T_R_AE2_N_S_K_R_IH1_P_SH_AH0_N AH0_N_D DH_EH1_R_F_AO2_R    IH0_K_S_P_R_EH1_SH_AH0_N AH1_V DH_AH0 MGMT EH1_N_Z_AY2_M Since AE1_N MGMT EH1_N_Z_AY2_M K_AE1_N R_IH0_P_EH1_R OW1_N_L_IY0 W_AH1_N DNA alkylation D_UW1 T_UW1 IH1_T_S S_UW1_AH0_S_AY2_D R_IH0_P_EH1_R M_EH1_K_AH0_N_IH2_Z_AH0_M    R_IH0_V_ER1_S K_AH0_P_AE1_S_AH0_T_IY0 IH1_Z L_OW1 AH0_N_D methylation AH1_V DH_AH0 MGMT JH_IY1_N P_R_AH0_M_OW1_T_ER0 G_R_EY1_T_L_IY0 AH0_F_EH1_K_T_S DNA R_IH0_P_EH1_R K_AH0_P_AE1_S_AH0_T_IY0     Indeed    MGMT methylation IH1_Z AH0_S_OW1_S_IY0_EY2_T_AH0_D W_IH1_DH AE1_N IH2_M_P_R_UW1_V_D R_IH0_S_P_AA1_N_S T_UW1 T_R_IY1_T_M_AH0_N_T W_IH1_DH DNA D_AE1_M_IH0_JH_IH0_NG chemotherapeutics    S_AH1_CH AE1_Z temozolomide    Cancer S_EH1_L_Z W_IH1_DH P_R_AA1_P_ER0_T_IY0_Z S_IH1_M_AH0_L_ER0 T_UW1 S_T_EH1_M S_EH1_L_Z HH_AE1_V B_IH1_N F_AW1_N_D IH0_N glioblastomas    DH_IH1_S M_EY1 B_IY1 AH0 K_AA1_Z AH1_V DH_EH1_R R_IH0_Z_IH1_S_T_AH0_N_S T_UW1 K_AH0_N_V_EH1_N_SH_AH0_N_AH0_L T_R_IY1_T_M_AH0_N_T_S    AH0_N_D HH_AY1 R_IH0_K_ER1_AH0_N_S R_EY1_T    These S_OW1 K_AO1_L_D glioblastoma S_T_EH1_M L_AY1_K S_EH1_L_Z R_IH0_Z_AY1_D IH0_N AH0 N_IH1_SH ER0_AW1_N_D arterioles    P_R_AH0_T_EH1_K_T_IH0_NG DH_IY1_Z S_EH1_L_Z AH0_G_EH1_N_S_T TH_EH1_R_AH0_P_IY0 B_AY1 M_EY0_N_T_EY1_N_IH0_NG AH0 R_EH1_L_AH0_T_IH0_V_L_IY0 hypoxic IH0_N_V_AY1_R_AH0_N_M_AH0_N_T    biomarker F_AO1_R S_EH1_L_Z IH0_N glioblastomas DH_AE1_T IH0_G_Z_IH1_B_IH0_T K_AE1_N_S_ER0 S_T_EH1_M S_EH1_L P_R_AA1_P_ER0_T_IY0_Z    DH_AH0 T_R_AE2_N_S_K_R_IH1_P_SH_AH0_N F_AE1_K_T_ER0 Hes3    HH_AE1_Z B_IH1_N SH_OW1_N T_UW1 R_EH1_G_Y_AH0_L_EY2_T DH_EH1_R N_AH1_M_B_ER0 W_EH1_N P_L_EY1_S_T IH0_N K_AH1_L_CH_ER0    The IDH1 JH_IY1_N encodes F_AO1_R DH_AH0 EH1_N_Z_AY2_M isocitrate dehydrogenase AH0_N_D IH1_Z F_R_IY1_K_W_AH0_N_T_L_IY0 M_Y_UW1_T_EY2_T_IH0_D IH0_N glioblastoma    P_R_AY1_M_EH2_R_IY0 GBM    %   S_EH1_K_AH0_N_D_EH2_R_IY0 GBM  > 80 %     By P_R_AH0_D_UW1_S_IH0_NG V_EH1_R_IY0 HH_AY1 K_AA2_N_S_AH0_N_T_R_EY1_SH_AH0_N_Z AH1_V DH_AH0    oncometabolite    hydroxyglutarate AH0_N_D dysregulating DH_AH0 F_AH1_NG_K_SH_AH0_N AH1_V DH_AH0 W_AY1_L_D T_AY1_P IDH1 EH1_N_Z_AY2_M IH1_T IH2_N_D_UW1_S_IH0_Z P_R_OW0_F_AW1_N_D CH_EY1_N_JH_AH0_Z T_UW1 DH_AH0 M_AH0_T_AE1_B_AH0_L_IH2_Z_AH0_M AH1_V IDH1 M_Y_UW1_T_EY2_T_IH0_D glioblastoma    K_AH0_M_P_EH1_R_D W_IH1_DH IDH1 W_AY1_L_D T_AY1_P glioblastoma AO1_R HH_EH1_L_TH_IY0 astrocytes Among AH1_DH_ER0_Z    IH1_T IH2_N_K_R_IY1_S_IH0_Z DH_AH0 glioblastoma S_EH1_L_Z D_IH0_P_EH1_N_D_AH0_N_S AA1_N glutamine AO1_R G_L_UW1_T_AH0_M_EY2_T AE1_Z AE1_N EH1_N_ER0_JH_IY0 S_AO1_R_S    It HH_AE1_Z B_IH1_N HH_AY0_P_AA1_TH_AH0_S_AY2_Z_D DH_AE1_T IDH1 M_Y_UW1_T_EY2_T_IH0_D glioblastoma AA1_R IH0_N AH0 V_EH1_R_IY0 HH_AY1 D_IH0_M_AE1_N_D F_AO1_R G_L_UW1_T_AH0_M_EY2_T AH0_N_D Y_UW1_S DH_IH1_S AH0_M_IY1_N_OW0 AE1_S_AH0_D AH0_N_D neurotransmitter AE1_Z AH0 chemotactic S_IH1_G_N_AH0_L Since HH_EH1_L_TH_IY0 astrocytes IH0_K_S_K_R_IY1_T G_L_UW1_T_AH0_M_EY2_T    IDH1 M_Y_UW1_T_EY2_T_IH0_D glioblastoma S_EH1_L_Z D_UW1 N_AA1_T F_EY1_V_ER0 D_EH1_N_S T_UW1_M_ER0 S_T_R_AH1_K_CH_ER0_Z B_AH1_T IH2_N_S_T_EH1_D M_AY1_G_R_EY2_T    IH2_N_V_EY1_D AH0_N_D D_IH0_S_P_ER1_S IH1_N_T_UW0 HH_EH1_L_TH_IY0 P_AA1_R_T_S AH1_V DH_AH0 B_R_EY1_N W_EH1_R G_L_UW1_T_AH0_M_EY2_T K_AA2_N_S_AH0_N_T_R_EY1_SH_AH0_N_Z AA1_R HH_AY1_ER0 This M_EY1 IH0_K_S_P_L_EY1_N DH_AH0 IH2_N_V_EY1_S_IH0_V B_IH0_HH_EY1_V_Y_ER0 AH1_V DH_IY1_Z IDH1 M_Y_UW1_T_EY2_T_IH0_D glioblastoma    Furthermore    glioblastoma multiforme IH0_G_Z_IH1_B_AH0_T_S N_UW1_M_ER0_AH0_S AO2_L_T_ER0_EY1_SH_AH0_N_Z IH0_N JH_IY1_N_Z DH_AE1_T EH0_N_K_OW1_D F_AO1_R AY1_AA2_N CH_AE1_N_AH0_L_Z    IH2_N_K_L_UW1_D_IH0_NG upregulation AH1_V gBK P_AH0_T_AE1_S_IY0_AH0_M CH_AE1_N_AH0_L_Z AH0_N_D ClC K_L_AO1_R_AY0_D CH_AE1_N_AH0_L_Z It HH_AE1_Z B_IH1_N HH_AY0_P_AA1_TH_AH0_S_AY2_Z_D DH_AE1_T B_AY1 upregulating DH_IY1_Z AY1_AA2_N CH_AE1_N_AH0_L_Z    glioblastoma T_UW1_M_ER0 S_EH1_L_Z K_AE1_N F_AH0_S_IH1_L_AH0_T_EY2_T IH2_N_K_R_IY1_S_T AY1_AA2_N M_UW1_V_M_AH0_N_T OW1_V_ER0 DH_AH0 S_EH1_L M_EH1_M_B_R_EY2_N    DH_EH1_R_B_AY1 IH2_N_K_R_IY1_S_IH0_NG H2O M_UW1_V_M_AH0_N_T TH_R_UW1 AO2_Z_M_OW1_S_IH0_S    W_IH1_CH EY1_D_Z glioblastoma S_EH1_L_Z IH0_N CH_EY1_N_JH_IH0_NG S_EH1_L_Y_AH0_L_ER0 V_AA1_L_Y_UW0_M V_EH1_R_IY0 R_AE1_P_AH0_D_L_IY0 This IH1_Z HH_EH1_L_P_F_AH0_L IH0_N DH_EH1_R IH0_K_S_T_R_IY1_M_L_IY0 AH0_G_R_EH1_S_IH0_V IH2_N_V_EY1_S_IH0_V B_IH0_HH_EY1_V_Y_ER0    B_IH0_K_AO1_Z K_W_IH1_K AE2_D_AE0_P_T_EY1_SH_AH0_N_Z IH0_N S_EH1_L_Y_AH0_L_ER0 V_AA1_L_Y_UW0_M K_AE1_N F_AH0_S_IH1_L_AH0_T_EY2_T M_UW1_V_M_AH0_N_T TH_R_UW1 DH_AH0 S_IH1_N_W_AH0_S extracellular M_EY1_T_R_IH0_K_S AH1_V DH_AH0 B_R_EY1_N    When V_Y_UW1_D W_IH1_DH MRI    glioblastomas AO1_F_T_AH0_N AH0_P_IH1_R AE1_Z R_IH1_NG EH0_N_HH_AE1_N_S_IH0_NG L_IY1_ZH_AH0_N_Z    The AH0_P_IH1_R_AH0_N_S IH1_Z N_AA1_T S_P_AH0_S_IH1_F_IH0_K    HH_AW2_EH1_V_ER0    AE1_Z AH1_DH_ER0 L_IY1_ZH_AH0_N_Z S_AH1_CH AE1_Z AE1_B_S_EH2_S    M_AH0_T_AE1_S_T_AH0_S_IH0_S    tumefactive M_AH1_L_T_AH0_P_AH0_L S_K_L_ER0_OW1_S_AH0_S    AH0_N_D AH1_DH_ER0 EH1_N_T_IH0_T_IY0_Z M_EY1 HH_AE1_V AH0 S_IH1_M_AH0_L_ER0 AH0_P_IH1_R_AH0_N_S    Definitive D_AY2_AH0_G_N_OW1_S_AH0_S AH1_V AH0 S_AH0_S_P_EH1_K_T_AH0_D GBM AA1_N CT AO1_R MRI R_IY0_K_W_AY1_ER0_Z AH0 S_T_EH2_R_IY0_OW2_T_AE1_K_T_IH0_K B_AY1_AA0_P_S_IY0 AO1_R AH0 craniotomy W_IH1_DH T_UW1_M_ER0 resection AH0_N_D pathologic K_AA2_N_F_ER0_M_EY1_SH_AH0_N    Because DH_AH0 T_UW1_M_ER0 G_R_EY1_D IH1_Z B_EY1_S_T AH0_P_AA1_N DH_AH0 M_OW1_S_T M_AH0_L_IH1_G_N_AH0_N_T P_AO1_R_SH_AH0_N AH1_V DH_AH0 T_UW1_M_ER0    B_AY1_AA0_P_S_IY0 AO1_R subtotal T_UW1_M_ER0 resection K_AE1_N R_IH0_Z_AH1_L_T IH0_N undergrading AH1_V DH_AH0 L_IY1_ZH_AH0_N Imaging AH1_V T_UW1_M_ER0 B_L_AH1_D F_L_OW1 Y_UW1_Z_IH0_NG perfusion MRI AH0_N_D M_EH1_ZH_ER0_IH0_NG T_UW1_M_ER0 metabolite K_AA2_N_S_AH0_N_T_R_EY1_SH_AH0_N W_IH1_DH MR S_P_EH0_K_T_R_AA1_S_K_AH0_P_IY0 M_EY1 AE1_D V_AE1_L_Y_UW0 T_UW1 S_T_AE1_N_D_ER0_D MRI IH0_N S_AH0_L_EH1_K_T K_EY1_S_AH0_Z B_AY1 SH_OW1_IH0_NG IH2_N_K_R_IY1_S_T R_EH1_L_AH0_T_IH0_V S_EH1_R_AH0_B_R_AH0_L B_L_AH1_D V_AA1_L_Y_UW0_M AH0_N_D IH2_N_K_R_IY1_S_T choline P_IY1_K R_IH0_S_P_EH1_K_T_IH0_V_L_IY0    B_AH1_T P_AH0_TH_AA1_L_AH0_JH_IY0 R_IH0_M_EY1_N_Z DH_AH0 G_OW1_L_D S_T_AE1_N_D_ER0_D F_AO1_R D_AY2_AH0_G_N_OW1_S_AH0_S AH0_N_D M_AH0_L_EH1_K_Y_AH0_L_ER0 K_EH2_R_IH0_K_T_ER0_IH0_Z_EY1_SH_AH0_N It IH1_Z IH2_M_P_AO1_R_T_AH0_N_T T_UW1 D_IH0_S_T_IH1_NG_G_W_IH0_SH P_R_AY1_M_EH2_R_IY0 glioblastoma F_R_AH1_M S_EH1_K_AH0_N_D_EH2_R_IY0 glioblastoma These T_UW1_M_ER0_Z AH0_K_ER1 S_P_AA0_N_T_EY1_N_IY0_AH0_S_L_IY0    D_IY1 N_OW1_V_OW0    AO1_R HH_AE1_V P_R_AH0_G_R_EH1_S_T F_R_AH1_M AH0 L_OW1_ER0 G_R_EY1_D glioma    R_IH0_S_P_EH1_K_T_IH0_V_L_IY0    Primary glioblastomas HH_AE1_V AH0 W_ER1_S P_R_AA0_G_N_OW1_S_AH0_S    D_IH1_F_ER0_AH0_N_T T_UW1_M_ER0 B_AY0_AA1_L_AH0_JH_IY0 AH0_N_D M_EY1 HH_AE1_V AH0 D_IH1_F_ER0_AH0_N_T R_IH0_S_P_AA1_N_S T_UW1 TH_EH1_R_AH0_P_IY0    W_IH1_CH M_EY1_K_S DH_IH1_S AH0 K_R_IH1_T_IH0_K_AH0_L IH0_V_AE2_L_Y_UW0_EY1_SH_AH0_N T_UW1 D_AH0_T_ER1_M_AH0_N P_EY1_SH_AH0_N_T P_R_AA0_G_N_OW1_S_AH0_S AH0_N_D TH_EH1_R_AH0_P_IY0    Over 80 %  AH1_V S_EH1_K_AH0_N_D_EH2_R_IY0 glioblastoma K_AE1_R_IY0_Z AH0 M_Y_UW0_T_EY1_SH_AH0_N IH0_N IDH1    W_EH0_R_AE1_Z DH_IH1_S M_Y_UW0_T_EY1_SH_AH0_N IH1_Z R_EH1_R IH0_N P_R_AY1_M_EH2_R_IY0 glioblastoma    10 %  Thus    IDH1 M_Y_UW0_T_EY1_SH_AH0_N_Z AA1_R AH0 Y_UW1_S_F_AH0_L T_UW1_L T_UW1 D_IH0_S_T_IH1_NG_G_W_IH0_SH P_R_AY1_M_EH2_R_IY0 AH0_N_D S_EH1_K_AH0_N_D_EH2_R_IY0 glioblastomas    S_IH1_N_S histopathologically DH_EY1 AA1_R V_EH1_R_IY0 S_IH1_M_AH0_L_ER0 AH0_N_D DH_AH0 D_IH0_S_T_IH1_NG_K_SH_AH0_N W_IH0_TH_AW1_T M_AH0_L_EH1_K_Y_AH0_L_ER0 biomarkers IH1_Z AH2_N_R_IH0_L_AY1_AH0_B_AH0_L    It IH1_Z V_EH1_R_IY0 D_IH1_F_AH0_K_AH0_L_T T_UW1 T_R_IY1_T glioblastoma D_UW1 T_UW1 S_EH1_V_ER0_AH0_L K_AA1_M_P_L_AH0_K_EY2_T_IH0_NG F_AE1_K_T_ER0_Z     Treatment AH1_V P_R_AY1_M_EH2_R_IY0 B_R_EY1_N T_UW1_M_ER0_Z AH0_N_D B_R_EY1_N metastases K_AH0_N_S_IH1_S_T_S AH1_V B_OW1_TH S_IH2_M_P_T_AH0_M_AE1_T_IH0_K AH0_N_D P_AE1_L_IY0_AH0_T_IH0_V TH_EH1_R_AH0_P_IY0_Z Supportive T_R_IY1_T_M_AH0_N_T F_OW1_K_AH0_S_IH0_Z AA1_N R_IH0_L_IY1_V_IH0_NG S_IH1_M_P_T_AH0_M_Z AH0_N_D IH2_M_P_R_UW1_V_IH0_NG DH_AH0 P_EY1_SH_AH0_N_T EH1_S N_UH2_R_AH0_L_AA1_JH_IH0_K F_AH1_NG_K_SH_AH0_N The P_R_AY1_M_EH2_R_IY0 S_AH0_P_AO1_R_T_IH0_V EY1_JH_AH0_N_T_S AA1_R anticonvulsants AH0_N_D K_AO2_R_T_IH0_K_OW0_S_T_EH1_R_OY2_D_Z Palliative T_R_IY1_T_M_AH0_N_T Y_UW1_ZH_AH0_W_AH0_L_IY0 IH1_Z K_AH0_N_D_AH1_K_T_AH0_D T_UW1 IH2_M_P_R_UW1_V K_W_AA1_L_AH0_T_IY0 AH1_V L_AY1_F AH0_N_D T_UW1 AH0_CH_IY1_V AH0 L_AO1_NG_G_ER0 S_ER0_V_AY1_V_AH0_L T_AY1_M It IH2_N_K_L_UW1_D_Z S_ER1_JH_ER0_IY0    R_EY2_D_IY0_EY1_SH_AH0_N TH_EH1_R_AH0_P_IY0    AH0_N_D K_IY2_M_OW0_TH_EH1_R_AH0_P_IY0 maximally F_IY1_Z_AH0_B_AH0_L resection W_IH1_DH M_AE1_K_S_AH0_M_AH0_L T_UW1_M_ER0 F_R_IY1 M_AA1_R_JH_AH0_N_Z IH1_Z Y_UW1_ZH_AH0_W_AH0_L_IY0 P_ER0_F_AO1_R_M_D AH0_L_AO1_NG W_IH1_DH IH0_K_S_T_ER1_N_AH0_L B_IY1_M R_EY2_D_IY0_EY1_SH_AH0_N AH0_N_D K_IY2_M_OW0_TH_EH1_R_AH0_P_IY0    Gross T_OW1_T_AH0_L resection AH1_V T_UW1_M_ER0 IH1_Z AH0_S_OW1_S_IY0_EY2_T_AH0_D W_IH1_DH AH0 B_EH1_T_ER0 P_R_AA0_G_N_OW1_S_AH0_S Surgery IH1_Z DH_AH0 F_ER1_S_T S_T_EY1_JH AH1_V T_R_IY1_T_M_AH0_N_T AH1_V glioblastoma An AE1_V_ER0_IH0_JH GBM T_UW1_M_ER0 K_AH0_N_T_EY1_N_Z 1011 S_EH1_L_Z    W_IH1_CH IH1_Z AA1_N AE1_V_ER0_IH0_JH R_IH0_D_UW1_S_T T_UW1 109 S_EH1_L_Z AE1_F_T_ER0 S_ER1_JH_ER0_IY0    AH0 R_IH0_D_AH1_K_SH_AH0_N AH1_V 99 %  Benefits AH1_V S_ER1_JH_ER0_IY0 IH2_N_K_L_UW1_D resection F_AO1_R AH0 P_AE2_TH_AH0_L_AA1_JH_IH0_K_AH0_L D_AY2_AH0_G_N_OW1_S_AH0_S    AH0_L_IY2_V_IY0_EY1_SH_AH0_N AH1_V S_IH1_M_P_T_AH0_M_Z R_IH0_L_EY1_T_IH0_D T_UW1 M_AE1_S IH0_F_EH1_K_T    AH0_N_D P_AH0_T_EH1_N_SH_AH0_L_IY0 R_IY0_M_UW1_V_IH0_NG D_IH0_Z_IY1_Z B_IH0_F_AO1_R S_EH1_K_AH0_N_D_EH2_R_IY0 R_IH0_Z_IH1_S_T_AH0_N_S T_UW1 radiotherapy AH0_N_D K_IY2_M_OW0_TH_EH1_R_AH0_P_IY0 AH0_K_ER1_Z The G_R_EY1_T_ER0 DH_AH0 IH0_K_S_T_EH1_N_T AH1_V T_UW1_M_ER0 R_IH0_M_UW1_V_AH0_L    DH_AH0 B_EH1_T_ER0 Removal AH1_V 98 %  AO1_R M_AO1_R AH1_V DH_AH0 T_UW1_M_ER0 HH_AE1_Z B_IH1_N AH0_S_OW1_S_IY0_EY2_T_AH0_D W_IH1_DH AH0 S_IH0_G_N_IH1_F_IH0_K_AH0_N_T_L_IY0 L_AO1_NG_G_ER0 HH_EH1_L_TH_IY0_ER0 T_AY1_M DH_AE1_N IH1_F L_EH1_S DH_AE1_N 98 %  AH1_V DH_AH0 T_UW1_M_ER0 IH1_Z R_IY0_M_UW1_V_D IH0_N R_EH2_T_R_AH0_S_P_EH1_K_T_IH0_V AE0_N_AE1_L_IH0_S_IY2_Z    The CH_AE1_N_S_AH0_Z AH1_V N_IH1_R K_AH0_M_P_L_IY1_T IH2_N_IH1_SH_AH0_L R_IH0_M_UW1_V_AH0_L AH1_V DH_AH0 T_UW1_M_ER0 M_EY1 B_IY1 IH2_N_K_R_IY1_S_T IH1_F DH_AH0 S_ER1_JH_ER0_IY0 IH1_Z G_AY1_D_AH0_D B_AY1 AH0 F_L_UH2_R_EH1_S_AH0_N_T D_AY1 N_OW1_N AE1_Z aminolevulinic AE1_S_AH0_D    GBM S_EH1_L_Z AA1_R W_AY1_D_L_IY0 infiltrative TH_R_UW1 DH_AH0 B_R_EY1_N AE1_T D_AY2_AH0_G_N_OW1_S_AH0_S    AH0_N_D S_OW1 D_IH0_S_P_AY1_T AH0    T_OW1_T_AH0_L resection    AH1_V AO1_L AA1_B_V_IY0_AH0_S T_UW1_M_ER0    M_OW1_S_T P_IY1_P_AH0_L W_IH1_DH GBM L_EY1_T_ER0 D_IH0_V_EH1_L_AH0_P R_IH0_K_ER1_AH0_N_T T_UW1_M_ER0_Z IY1_DH_ER0 N_IH1_R DH_AH0 ER0_IH1_JH_AH0_N_AH0_L S_AY1_T AO1_R AE1_T M_AO1_R D_IH1_S_T_AH0_N_T L_OW0_K_EY1_SH_AH0_N_Z W_IH0_DH_IH1_N DH_AH0 B_R_EY1_N Other M_AH0_D_AE1_L_AH0_T_IY0_Z    T_IH1_P_IH0_K_L_IY0 R_EY2_D_IY0_EY1_SH_AH0_N AH0_N_D K_IY2_M_OW0_TH_EH1_R_AH0_P_IY0    AA1_R Y_UW1_Z_D AE1_F_T_ER0 S_ER1_JH_ER0_IY0 IH0_N AE1_N EH1_F_ER0_T T_UW1 S_AH0_P_R_EH1_S AH0_N_D S_L_OW1 R_IH0_K_ER1_AH0_N_T D_IH0_Z_IY1_Z Subsequent T_UW1 S_ER1_JH_ER0_IY0    radiotherapy B_IH0_K_AH1_M_Z DH_AH0 M_EY1_N_S_T_EY2 AH1_V T_R_IY1_T_M_AH0_N_T F_AO1_R P_IY1_P_AH0_L W_IH1_DH glioblastoma It IH1_Z T_IH1_P_IH0_K_L_IY0 P_ER0_F_AO1_R_M_D AH0_L_AO1_NG W_IH1_DH G_IH1_V_IH0_NG temozolomide    TMZ    P_IH1_V_AH0_T_AH0_L K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L K_AE1_R_IY0_D AW1_T IH0_N DH_AH0 ER1_L_IY0 1970s SH_OW1_D DH_AE1_T AH0_M_AH1_NG 303 GBM P_EY1_SH_AH0_N_T_S R_AE1_N_D_AH0_M_AY2_Z_D T_UW1 R_EY2_D_IY0_EY1_SH_AH0_N AO1_R nonradiation TH_EH1_R_AH0_P_IY0    DH_OW1_Z HH_UW1 R_AH0_S_IY1_V_D R_EY2_D_IY0_EY1_SH_AH0_N HH_AE1_D AH0 M_IY1_D_IY0_AH0_N S_ER0_V_AY1_V_AH0_L M_AO1_R DH_AE1_N D_AH1_B_AH0_L DH_OW1_Z HH_UW1 D_IH1_D N_AA1_T    Subsequent K_L_IH1_N_AH0_K_AH0_L R_IY0_S_ER1_CH HH_AE1_Z AH0_T_EH1_M_P_T_AH0_D T_UW1 B_IH1_L_D AA1_N DH_AH0 B_AE1_K_B_OW2_N AH1_V S_ER1_JH_ER0_IY0 F_AA1_L_OW0_D B_AY1 R_EY2_D_IY0_EY1_SH_AH0_N On AE1_V_ER0_IH0_JH    radiotherapy AE1_F_T_ER0 S_ER1_JH_ER0_IY0 K_AE1_N R_IH0_D_UW1_S DH_AH0 T_UW1_M_ER0 S_AY1_Z T_UW1 107 S_EH1_L_Z Whole B_R_EY1_N radiotherapy D_AH1_Z N_AA1_T IH2_M_P_R_UW1_V W_EH1_N K_AH0_M_P_EH1_R_D T_UW1 DH_AH0 M_AO1_R P_R_IH0_S_AY1_S AH0_N_D T_AA1_R_G_AH0_T_IH0_D TH_R_IY1 D_IH0_M_EH1_N_SH_AH0_N_AH0_L conformal radiotherapy    T_OW1_T_AH0_L R_EY2_D_IY0_EY1_SH_AH0_N D_OW1_S AH1_V 60 65 Gy HH_AE1_Z B_IH1_N F_AW1_N_D T_UW1 B_IY1 AA1_P_T_IH0_M_AH0_L F_AO1_R T_R_IY1_T_M_AH0_N_T    GBM T_UW1_M_ER0_Z AA1_R W_EH1_L N_OW1_N T_UW1 K_AH0_N_T_EY1_N Z_OW1_N_Z AH1_V T_IH1_S_Y_UW2 IH0_G_Z_IH1_B_IH0_T_IH0_NG HH_AY0_P_AA1_K_S_IY0_AH0 W_IH1_CH AA1_R HH_AY1_L_IY0 R_IH0_Z_IH1_S_T_AH0_N_T T_UW1 radiotherapy    Various AH0_P_R_OW1_CH_IH0_Z T_UW1 K_IY2_M_OW0_TH_EH1_R_AH0_P_IY0 radiosensitizers HH_AE1_V B_IH1_N P_ER0_S_UW1_D W_IH1_DH L_IH1_M_AH0_T_AH0_D S_AH0_K_S_EH1_S AE1_Z AH1_V    2016 AH0_P_D_EY1_T As AH1_V    2010 AH0_P_D_EY1_T    N_UW1_ER0 R_IY0_S_ER1_CH AH0_P_R_OW1_CH_IH0_Z IH2_N_K_L_UW1_D_AH0_D P_R_IY0_K_L_IH1_N_IH0_K_AH0_L AH0_N_D K_L_IH1_N_AH0_K_AH0_L IH2_N_V_EH2_S_T_AH0_G_EY1_SH_AH0_N_Z IH1_N_T_UW0 DH_AH0 Y_UW1_S AH1_V AE1_N AA1_K_S_AH0_JH_AH0_N D_IH0_F_Y_UW1_ZH_AH0_N EH0_N_HH_AE1_N_S_IH0_NG K_AA1_M_P_AW0_N_D S_AH1_CH AE1_Z T_R_AE1_N_Z S_OW1_D_IY0_AH0_M crocetinate    TSC    AE1_Z radiosensitizers     AH0_N_D AE1_Z AH1_V    2015 AH0_P_D_EY1_T    AH0 K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L W_AA1_Z AH2_N_D_ER0_W_EY1    Boron N_UW1_T_R_AA2_N K_AE1_P_CH_ER0 TH_EH1_R_AH0_P_IY0 HH_AE1_Z B_IH1_N T_EH1_S_T_IH0_D AE1_Z AE1_N AO0_L_T_ER1_N_AH0_T_IH0_V T_R_IY1_T_M_AH0_N_T F_AO1_R glioblastoma multiforme B_AH1_T IH1_Z N_AA1_T IH0_N K_AA1_M_AH0_N Y_UW1_S Most S_T_AH1_D_IY0_Z SH_OW1 N_OW1 B_EH1_N_AH0_F_IH0_T F_R_AH1_M DH_AH0 AH0_D_IH1_SH_AH0_N AH1_V K_IY2_M_OW0_TH_EH1_R_AH0_P_IY0 However    AH0 L_AA1_R_JH K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L AH1_V 575 P_AA0_R_T_IH1_S_AH0_P_AH0_N_T_S R_AE1_N_D_AH0_M_AY2_Z_D T_UW1 S_T_AE1_N_D_ER0_D R_EY2_D_IY0_EY1_SH_AH0_N V_ER1_S_AH0_S R_EY2_D_IY0_EY1_SH_AH0_N P_L_AH1_S temozolomide K_IY2_M_OW0_TH_EH1_R_AH0_P_IY0 SH_OW1_D DH_AE1_T DH_AH0 G_R_UW1_P R_AH0_S_IY1_V_IH0_NG temozolomide S_ER0_V_AY1_V_D AH0 M_IY1_D_IY0_AH0_N AH1_V 14 M_AH1_N_TH_S AE1_Z AH0_P_OW1_Z_D T_UW1 12 M_AH1_N_TH_S F_AO1_R DH_AH0 G_R_UW1_P R_AH0_S_IY1_V_IH0_NG R_EY2_D_IY0_EY1_SH_AH0_N AH0_L_OW1_N     This T_R_IY1_T_M_AH0_N_T R_AH0_ZH_IY1_M IH1_Z N_AW1 S_T_AE1_N_D_ER0_D F_AO1_R M_OW1_S_T K_EY1_S_AH0_Z AH1_V glioblastoma W_EH1_R DH_AH0 P_ER1_S_AH0_N IH1_Z N_AA1_T EH0_N_R_OW1_L_D IH0_N AH0 K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L     Temozolomide S_IY1_M_Z T_UW1 W_ER1_K B_AY1 sensitizing DH_AH0 T_UW1_M_ER0 S_EH1_L_Z T_UW1 R_EY2_D_IY0_EY1_SH_AH0_N    High D_OW1_S_AH0_Z AH1_V temozolomide IH0_N HH_AY1 G_R_EY1_D gliomas Y_IY1_L_D L_OW1 T_AA0_K_S_IH1_S_AH0_T_IY0    B_AH1_T DH_AH0 R_IH0_Z_AH1_L_T_S AA1_R K_AA1_M_P_R_AH0_B_AH0_L T_UW1 DH_AH0 S_T_AE1_N_D_ER0_D D_OW1_S_AH0_Z    Antiangiogenic TH_EH1_R_AH0_P_IY0 W_IH1_DH M_EH2_D_AH0_K_EY1_SH_AH0_N_Z S_AH1_CH AE1_Z bevacizumab K_AH0_N_T_R_OW1_L S_IH1_M_P_T_AH0_M_Z B_AH1_T D_UW1 N_AA1_T AH0_F_EH1_K_T OW1_V_ER0_AO2_L S_ER0_V_AY1_V_AH0_L    Alternating IH0_L_EH1_K_T_R_IH0_K F_IY1_L_D TH_EH1_R_AH0_P_IY0 IH1_Z AE1_N FDA AH0_P_R_UW1_V_D TH_EH1_R_AH0_P_IY0 F_AO1_R N_UW1_L_IY0 D_AY2_AH0_G_N_OW1_S_T    AH0_N_D R_IH0_K_ER1_AH0_N_T glioblastoma    In 2015    IH2_N_IH1_SH_AH0_L R_IH0_Z_AH1_L_T_S F_R_AH1_M AH0 F_EY1_Z TH_R_IY1 R_AE1_N_D_AH0_M_AY2_Z_D K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L AH1_V AO1_L_T_ER0_N_EY2_T_IH0_NG IH0_L_EH1_K_T_R_IH0_K F_IY1_L_D TH_EH1_R_AH0_P_IY0 P_L_AH1_S temozolomide IH0_N N_UW1_L_IY0 D_AY2_AH0_G_N_OW1_S_T glioblastoma R_IY2_P_AO1_R_T_AH0_D AH0 TH_R_IY1 M_AH1_N_TH IH2_M_P_R_UW1_V_M_AH0_N_T IH0_N P_R_AH0_G_R_EH1_SH_AH0_N F_R_IY1 S_ER0_V_AY1_V_AH0_L    AH0_N_D AH0 F_AY1_V M_AH1_N_TH IH2_M_P_R_UW1_V_M_AH0_N_T IH0_N OW1_V_ER0_AO2_L S_ER0_V_AY1_V_AH0_L K_AH0_M_P_EH1_R_D T_UW1 temozolomide TH_EH1_R_AH0_P_IY0 AH0_L_OW1_N      R_EH2_P_R_IH0_Z_EH1_N_T_IH0_NG DH_AH0 F_ER1_S_T L_AA1_R_JH T_R_AY1_AH0_L IH0_N AH0 D_EH0_K_EY1_D T_UW1 SH_OW1 AH0 S_ER0_V_AY1_V_AH0_L IH2_M_P_R_UW1_V_M_AH0_N_T IH0_N DH_IH1_S S_EH1_T_IH0_NG    Despite DH_IY1_Z R_IH0_Z_AH1_L_T_S    DH_AH0 EH1_F_IH0_K_AE2_S_IY0 AH1_V DH_IH1_S AH0_P_R_OW1_CH R_IH0_M_EY1_N_Z K_AA2_N_T_R_AH0_V_ER1_SH_AH0_L AH0_M_AH1_NG M_EH1_D_AH0_K_AH0_L EH1_K_S_P_ER0_T_S    The M_OW1_S_T K_AA1_M_AH0_N L_EH1_NG_K_TH AH1_V S_ER0_V_AY1_V_AH0_L F_AA1_L_OW0_IH0_NG D_AY2_AH0_G_N_OW1_S_AH0_S IH1_Z 12 T_UW1 15 M_AH1_N_TH_S    W_IH1_DH F_Y_UW1_ER0 DH_AE1_N %  T_UW1 %  AH1_V P_IY1_P_AH0_L S_ER0_V_AY1_V_IH0_NG L_AO1_NG_G_ER0 DH_AE1_N F_AY1_V Y_IH1_R_Z     Without T_R_IY1_T_M_AH0_N_T S_ER0_V_AY1_V_AH0_L IH1_Z T_IH1_P_IH0_K_L_IY0 M_AH1_N_TH_S    Increasing EY1_JH   >  60 Y_IH1_R_Z AH1_V EY1_JH    K_AE1_R_IY0_Z AH0 W_ER1_S prognostic R_IH1_S_K Death IH1_Z Y_UW1_ZH_AH0_W_AH0_L_IY0 D_UW1 T_UW1 W_AY1_D_S_P_R_EH1_D T_UW1_M_ER0 IH2_N_F_IH0_L_T_R_EY1_SH_AH0_N W_IH1_DH S_EH1_R_AH0_B_R_AH0_L IH0_D_IY1_M_AH0 AH0_N_D IH2_N_K_R_IY1_S_T IH2_N_T_R_AH0_K_R_EY1_N_IY0_AH0_L P_R_EH1_SH_ER0    G_UH1_D IH2_N_IH1_SH_AH0_L Karnofsky Performance Score    KPS    AH0_N_D MGMT methylation AA1_R AH0_S_OW1_S_IY0_EY2_T_AH0_D W_IH1_DH L_AO1_NG_G_ER0 S_ER0_V_AY1_V_AH0_L    DNA T_EH1_S_T K_AE1_N B_IY1 K_AH0_N_D_AH1_K_T_AH0_D AA1_N glioblastomas T_UW1 D_AH0_T_ER1_M_AH0_N W_EH1_DH_ER0 AO1_R N_AA1_T DH_AH0 P_R_AH0_M_OW1_T_ER0 AH1_V DH_AH0 MGMT JH_IY1_N IH1_Z methylated Patients W_IH1_DH AH0 methylated MGMT P_R_AH0_M_OW1_T_ER0 HH_AE1_V L_AO1_NG_G_ER0 S_ER0_V_AY1_V_AH0_L DH_AE1_N DH_OW1_Z W_IH1_DH AE1_N unmethylated MGMT P_R_AH0_M_OW1_T_ER0    D_UW1 IH0_N P_AA1_R_T T_UW1 IH2_N_K_R_IY1_S_T S_EH2_N_S_IH0_T_IH1_V_IH0_T_IY0 T_UW1 temozolomide    This DNA K_EH2_R_IH0_K_T_ER0_IH1_S_T_IH0_K IH1_Z IH2_N_T_R_IH1_N_S_IH0_K T_UW1 DH_AH0 P_EY1_SH_AH0_N_T AH0_N_D K_ER1_AH0_N_T_L_IY0 K_AE1_N_AA0_T B_IY1 AO1_L_T_ER0_D IH0_K_S_T_ER1_N_AH0_L_IY0 Another P_AA1_Z_AH0_T_IH0_V prognostic M_AA1_R_K_ER0 F_AO1_R glioblastoma P_EY1_SH_AH0_N_T_S IH1_Z M_Y_UW0_T_EY1_SH_AH0_N AH1_V DH_AH0 IDH1 JH_IY1_N     W_IH1_CH K_AE1_N B_IY1 T_EH1_S_T_IH0_D B_AY1 DNA B_EY1_S_T M_EH1_TH_AH0_D_Z AO1_R B_AY1 immunohistochemistry Y_UW1_Z_IH0_NG AE1_N AE1_N_T_IH0_B_AA2_D_IY0 AH0_G_EH1_N_S_T DH_AH0 M_OW1_S_T K_AA1_M_AH0_N M_Y_UW0_T_EY1_SH_AH0_N    N_EY1_M_L_IY0 IDH1 R132H    More prognostic P_AW1_ER0 K_AE1_N B_IY1 AH0_B_T_EY1_N_D B_AY1 K_AH0_M_B_AY1_N_IH0_NG DH_AH0 mutational S_T_AE1_T_AH0_S AH1_V IDH1 AH0_N_D DH_AH0 methylation S_T_AE1_T_AH0_S AH1_V MGMT IH1_N_T_UW0 AH0 T_UW1 JH_IY1_N P_R_IH0_D_IH1_K_T_ER0 Patients W_IH1_DH B_OW1_TH IDH1 M_Y_UW0_T_EY1_SH_AH0_N_Z AH0_N_D MGMT methylation HH_AE1_V DH_AH0 L_AO1_NG_G_AH0_S_T S_ER0_V_AY1_V_AH0_L    P_EY1_SH_AH0_N_T_S W_IH1_DH AE1_N IDH1 M_Y_UW0_T_EY1_SH_AH0_N AO1_R MGMT methylation AE1_N IH2_N_T_ER0_M_IY1_D_IY0_IH0_T S_ER0_V_AY1_V_AH0_L AH0_N_D P_EY1_SH_AH0_N_T_S W_IH0_TH_AW1_T IY1_DH_ER0 JH_AH0_N_EH1_T_IH0_K IH0_V_EH1_N_T HH_AE1_V DH_AH0 SH_AO1_R_T_IH0_S_T S_ER0_V_AY1_V_AH0_L    Long T_ER1_M B_EH1_N_AH0_F_IH0_T_S HH_AE1_V AO1_L_S_OW0 B_IH1_N AH0_S_OW1_S_IY0_EY2_T_AH0_D W_IH1_DH DH_OW1_Z P_EY1_SH_AH0_N_T_S HH_UW1 R_AH0_S_IY1_V S_ER1_JH_ER0_IY0    radiotherapy    AH0_N_D temozolomide K_IY2_M_OW0_TH_EH1_R_AH0_P_IY0    However    M_AH1_CH R_IH0_M_EY1_N_Z AH0_N_N_OW1_N AH0_B_AW1_T W_AY1 S_AH1_M P_EY1_SH_AH0_N_T_S S_ER0_V_AY1_V L_AO1_NG_G_ER0 W_IH1_DH glioblastoma Age AH1_V AH1_N_D_ER0 50 IH1_Z L_IH1_NG_K_T T_UW1 L_AO1_NG_G_ER0 S_ER0_V_AY1_V_AH0_L IH0_N glioblastoma multiforme    AE1_Z IH1_Z 98 %+  resection AH0_N_D Y_UW1_S AH1_V temozolomide K_IY2_M_OW0_TH_EH1_R_AH0_P_IY0 AH0_N_D B_EH1_T_ER0 Karnofsky P_ER0_F_AO1_R_M_AH0_N_S S_K_AO1_R_Z R_IY1_S_AH0_N_T S_T_AH1_D_IY0 K_AH0_N_F_ER1_M_Z DH_AE1_T Y_AH1_NG_G_ER0 EY1_JH IH1_Z AH0_S_OW1_S_IY0_EY2_T_AH0_D W_IH1_DH AH0 M_AH1_CH B_EH1_T_ER0 P_R_AA0_G_N_OW1_S_AH0_S    W_IH1_DH AH0 S_M_AO1_L F_R_AE1_K_SH_AH0_N AH1_V P_EY1_SH_AH0_N_T_S AH1_N_D_ER0 40 Y_IH1_R_Z AH1_V EY1_JH AH0_CH_IY1_V_IH0_NG AH0 P_AA2_P_Y_AH0_L_EY1_SH_AH0_N B_EY1_S_T K_Y_UH1_R The P_AA2_P_Y_AH0_L_EY1_SH_AH0_N B_EY1_S_T K_Y_UH1_R IH1_Z TH_AO1_T T_UW1 AH0_K_ER1 W_EH1_N AH0 P_AA2_P_Y_AH0_L_EY1_SH_AH0_N EH1_S R_IH1_S_K AH1_V D_EH1_TH R_IH0_T_ER1_N_Z T_UW1 DH_AE1_T AH1_V DH_AH0 N_AO1_R_M_AH0_L P_AA2_P_Y_AH0_L_EY1_SH_AH0_N    AH0_N_D IH0_N GBM    DH_IH1_S IH1_Z TH_AO1_T T_UW1 AH0_K_ER1 AE1_F_T_ER0 10 Y_IH1_R_Z    UCLA Neuro Oncology P_AH1_B_L_IH0_SH_AH0_Z R_IY1_L T_AY1_M S_ER0_V_AY1_V_AH0_L D_EY1_T_AH0 F_AO1_R P_EY1_SH_AH0_N_T_S W_IH1_DH DH_IH1_S D_AY2_AH0_G_N_OW1_S_AH0_S    They AA1_R DH_AH0 OW1_N_L_IY0 IH2_N_S_T_IH0_T_UW1_SH_AH0_N IH0_N DH_AH0 United States DH_AE1_T SH_OW1_Z HH_AW1 DH_EH1_R P_EY1_SH_AH0_N_T_S AA1_R P_ER0_F_AO1_R_M_IH0_NG They AO1_L_S_OW0 SH_OW1 AH0 L_IH1_S_T_IH0_NG AH1_V K_IY2_M_OW0_TH_EH1_R_AH0_P_IY0 EY1_JH_AH0_N_T_S Y_UW1_Z_D T_UW1 T_R_IY1_T GBM T_UW1_M_ER0_Z Despite AH0 P_UW1_R P_R_AA0_G_N_OW1_S_AH0_S    DH_EH1_R IH1_Z AH0 S_M_AO1_L N_AH1_M_B_ER0 AH1_V S_ER0_V_AY1_V_ER0_Z HH_UW1 HH_AE1_V B_IH1_N GBM F_R_IY1 F_AO1_R M_AO1_R DH_AE1_N 10 20 Y_IH1_R_Z According T_UW1 AH0 2003 S_T_AH1_D_IY0    glioblastoma multiforme P_R_AA0_G_N_OW1_S_AH0_S K_AE1_N B_IY1 D_IH0_V_AY1_D_IH0_D IH1_N_T_UW0 TH_R_IY1 S_AH1_B_G_R_UW2_P_S D_IH0_P_EH1_N_D_AH0_N_T AA1_N KPS    DH_AH0 EY1_JH AH1_V DH_AH0 P_EY1_SH_AH0_N_T    AH0_N_D T_R_IY1_T_M_AH0_N_T    About P_ER1 100 000 P_IY1_P_AH0_L D_IH0_V_EH1_L_AH0_P DH_AH0 D_IH0_Z_IY1_Z AH0 Y_IH1_R    It M_OW1_S_T AO1_F_T_AH0_N B_IH0_G_IH1_N_Z ER0_AW1_N_D 64 Y_IH1_R_Z AH1_V EY1_JH AH0_N_D AH0_K_ER1_Z M_AO1_R K_AA1_M_AH0_N_L_IY0 IH0_N M_EY1_L_Z DH_AE1_N F_IY1_M_EY2_L_Z     It IH1_Z DH_AH0 S_EH1_K_AH0_N_D M_OW1_S_T K_AA1_M_AH0_N S_EH1_N_T_R_AH0_L N_ER1_V_AH0_S S_IH1_S_T_AH0_M K_AE1_N_S_ER0 AE1_F_T_ER0 meningioma    The T_ER1_M glioblastoma multiforme W_AA1_Z IH2_N_T_R_AH0_D_UW1_S_T IH0_N 1926 B_AY1 Percival Bailey AH0_N_D Harvey Cushing    B_EY1_S_T AA1_N DH_AH0 AY0_D_IY1_AH0 DH_AE1_T DH_AH0 T_UW1_M_ER0 ER0_IH1_JH_AH0_N_EY2_T_S F_R_AH1_M P_R_IH1_M_AH0_T_IH0_V P_R_IY0_K_ER1_S_ER0_Z AH1_V glial S_EH1_L_Z    glioblasts     AH0_N_D DH_AH0 HH_AY1_L_IY0 V_EH1_R_IY0_AH0_B_AH0_L AH0_P_IH1_R_AH0_N_S D_UW1 T_UW1 DH_AH0 P_R_EH1_Z_AH0_N_S AH1_V N_AH0_K_R_OW1_S_AH0_S    HH_EH1_M_ER0_IH0_JH AH0_N_D S_IH1_S_T_S    multiform    As AH1_V 2012    RNA IH2_N_T_ER0_F_IH1_R_AH0_N_S    Y_UW1_ZH_AH0_W_AH0_L_IY0 microRNA    W_AA1_Z AH1_N_D_ER0 IH2_N_V_EH2_S_T_AH0_G_EY1_SH_AH0_N IH0_N T_IH1_S_Y_UW2 K_AH1_L_CH_ER0    P_AH0_TH_AA1_L_AH0_JH_IY0 S_P_EH1_S_AH0_M_AH0_N_Z AH0_N_D IH0_N P_R_IY0_K_L_IH1_N_IH0_K_AH0_L AE1_N_AH0_M_AH0_L M_AA1_D_AH0_L_Z AH1_V glioblastoma    Gene TH_EH1_R_AH0_P_IY0 HH_AE1_Z B_IH1_N IH0_K_S_P_L_AO1_R_D AE1_Z AH0 M_EH1_TH_AH0_D T_UW1 T_R_IY1_T glioblastoma AH0_N_D W_AY1_L AE1_N_AH0_M_AH0_L M_AA1_D_AH0_L_Z AH0_N_D ER1_L_IY0 F_EY1_Z K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L_Z HH_AE1_V B_IH1_N S_AH0_K_S_EH1_S_F_AH0_L    AE1_Z AH1_V 2017    AO1_L JH_IY1_N TH_EH1_R_AH0_P_IY0 D_R_AH1_G_Z DH_AE1_T HH_AE1_D B_IH1_N T_EH1_S_T_IH0_D IH0_N F_EY1_Z III K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L_Z F_AO1_R glioblastoma HH_AE1_D F_EY1_L_D      P_R_AA1_M_AH0_S_IH0_NG N_UW1 D_ER0_EH1_K_SH_AH0_N AH1_V R_IY0_S_ER1_CH    S_IH1_N_S 2017    IH1_Z DH_AH0 Y_UW1_S AH1_V DH_AH0 Zika V_AY1_R_AH0_S W_IH1_CH HH_AE1_Z SH_OW1_N P_R_AA1_M_AH0_S IH0_N S_P_AH0_S_IH1_F_IH0_K_L_IY0 T_AA1_R_G_AH0_T_IH0_NG glioma S_T_EH1_M S_EH1_L_Z W_AY1_L L_IY1_V_IH0_NG AH0_D_AH1_L_T B_R_EY1_N S_EH1_L_Z AH2_N_AH0_F_EH1_K_T_IH0_D      Direct N_OW1_Z T_UW1 B_R_EY1_N D_R_AH1_G D_IH0_L_IH1_V_ER0_IY0 IH1_Z B_IY1_IH0_NG IH0_K_S_P_L_AO1_R_D AE1_Z AH0 M_IY1_N_Z T_UW1 AH0_CH_IY1_V HH_AY1_ER0    AH0_N_D HH_OW1_P_F_AH0_L_IY0 M_AO1_R IH0_F_EH1_K_T_IH0_V    D_R_AH1_G K_AA2_N_S_AH0_N_T_R_EY1_SH_AH0_N_Z IH0_N DH_AH0 B_R_EY1_N     K_L_IH1_N_AH0_K_AH0_L F_EY1_Z II S_T_AH1_D_IY0 W_IH1_DH glioblastoma P_EY1_SH_AH0_N_T_S IH0_N Brazil IH2_N_V_EH1_S_T_AH0_G_EY2_T_AH0_D DH_AH0 N_AE1_CH_ER0_AH0_L K_AA1_M_P_AW0_N_D perillyl AE1_L_K_AH0_HH_AA2_L F_AO1_R intranasal D_IH0_L_IH1_V_ER0_IY0 AE1_Z AE1_N EH1_R_AH0_S_AA2_L The R_IH0_Z_AH1_L_T_S W_ER1 EH0_N_K_ER1_IH0_JH_IH0_NG      AH0_N_D    AE1_Z AH1_V 2016    AH0 S_IH1_M_AH0_L_ER0 T_R_AY1_AH0_L HH_AE1_Z B_IH1_N IH2_N_IH1_SH_IY0_EY2_T_AH0_D IH0_N DH_AH0 United States    Research HH_AE1_Z B_IH1_N D_AH1_N T_UW1 S_IY1 IH1_F K_AH0_N_S_AH1_M_P_SH_AH0_N AH1_V K_Y_UH1_R_D M_IY1_T IH1_Z AH0 R_IH1_S_K F_AE1_K_T_ER0 No R_IH1_S_K HH_AE1_D B_IH1_N K_AH0_N_F_ER1_M_D AE1_Z AH1_V 2013     Similarly    IH0_K_S_P_OW1_ZH_ER0 T_UW1 R_EY2_D_IY0_EY1_SH_AH0_N D_UH1_R_IH0_NG M_EH1_D_AH0_K_AH0_L IH1_M_IH0_JH_IH0_NG    F_AO0_R_M_AE1_L_D_AH0_HH_AY2_D    AH0_N_D R_EH2_Z_IH0_D_EH1_N_SH_AH0_L IH2_L_EH2_K_T_R_OW0_M_AE0_G_N_EH1_T_IH0_K F_IY1_L_D_Z    S_AH1_CH AE1_Z F_R_AH1_M S_EH1_L F_OW1_N_Z AH0_N_D IH0_L_EH1_K_T_R_IH0_K_AH0_L W_AY1_R_IH0_NG W_IH0_DH_IH1_N HH_OW1_M_Z    HH_AE1_V B_IH1_N S_T_AH1_D_IY0_D AE1_Z R_IH1_S_K F_AE1_K_T_ER0_Z As AH1_V 2015    DH_EY1 HH_AE1_D N_AA1_T B_IH1_N SH_OW1_N T_UW1 K_AA1_Z GBM      However    AH0 M_IY1_T_AH0 AE0_N_AE1_L_IH0_S_IH0_S P_AH1_B_L_IH0_SH_T IH0_N 2007    F_AW1_N_D AH0 K_AO2_R_AH0_L_EY1_SH_AH0_N B_IH0_T_W_IY1_N IH2_N_K_R_IY1_S_T IH1_N_S_AH0_D_AH0_N_S AH1_V GBM AH0_N_D Y_UW1_S AH1_V AH0 S_EH1_L F_OW1_N F_AO1_R L_AO1_NG_G_ER0 DH_AE1_N 10 Y_IH1_R_Z    AH0_S_P_EH1_SH_L_IY0 AH0_M_AH1_NG DH_OW1_Z HH_UW1 AO1_L_W_EY2_Z HH_EH1_L_D DH_AH0 F_OW1_N AA1_N W_AH1_N S_AY1_D AH1_V DH_EH1_R HH_EH1_D   